📊 NATR Key Takeaways
Is Natures Sunshine Products Inc. (NATR) a Good Investment?
Nature's Sunshine Products exhibits strong fundamentals with excellent gross margins (73.2%), fortress balance sheet, and minimal debt, but is hampered by negative operating cash flow (-$1.8M) and weak capital returns (ROE 3.1%, ROA 2.0%) despite positive earnings. The divergence between flat net income growth and 165% EPS growth indicates aggressive buybacks, masking underlying operational stagnation that must be monitored.
Natures Sunshine shows solid fundamentals with a cash-rich, minimally levered balance sheet, high gross margins, and consistent free cash flow generation. However, operating efficiency remains modest and net income is flat despite revenue growth, suggesting limited earnings leverage. Evidence of sustained margin expansion and steadier earnings growth would strengthen the case.
Natures Sunshine Products Inc. Key Strengths (NATR)
- Exceptional gross margin of 73.2% demonstrates strong pricing power in pharmaceutical segment
- Fortress balance sheet with $87.6M cash, $2.1M debt, and 0.01x debt-to-equity ratio
- Excellent liquidity with 2.50x current ratio and 138.3x interest coverage
- Net cash balance sheet with negligible debt and strong coverage
- High gross margin and good FCF conversion (6% FCF margin)
- Healthy liquidity (2.28x current) and respectable ROE (12%)
NATR Stock Risks: Natures Sunshine Products Inc. Investment Risks
- Negative operating cash flow (-$1.8M) and free cash flow (-$4.3M) despite positive earnings signals quality-of-earnings or working capital deterioration
- Abysmal capital returns with ROE of 3.1% and ROA of 2.0% despite healthy margins indicates operational inefficiency
- Flat net income growth (0.0% YoY) and modest revenue growth (5.7%) suggest business maturity or headwinds in core operations
- Low operating margin (5.2%) limits earnings scalability
- Regulatory/channel risks in supplements and FX exposure
- Modest top-line growth with potential competitive and distributor churn pressures
Key Metrics to Watch
- Operating cash flow trend - must return to positive
- Working capital changes - investigate what is driving cash burn
- Segment performance and customer retention in pharmaceutical/direct sales channels
- Operating margin
- Organic revenue growth (constant currency)
Natures Sunshine Products Inc. (NATR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.50x current ratio provides a solid financial cushion.
NATR Profit Margin, ROE & Profitability Analysis
NATR vs Healthcare Sector: How Natures Sunshine Products Inc. Compares
How Natures Sunshine Products Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Natures Sunshine Products Inc. Stock Overvalued? NATR Valuation Analysis 2026
Based on fundamental analysis, Natures Sunshine Products Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Natures Sunshine Products Inc. Balance Sheet: NATR Debt, Cash & Liquidity
NATR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Natures Sunshine Products Inc.'s revenue has shown modest growth of 8% over the 5-year period. The most recent EPS of $0.40 reflects profitable operations.
NATR Revenue Growth, EPS Growth & YoY Performance
NATR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $113.2M | $4.7M | $0.25 |
| Q3 2025 | $114.6M | $4.3M | $0.23 |
| Q2 2025 | $110.6M | $1.3M | $0.07 |
| Q1 2025 | $111.0M | $2.3M | $0.12 |
| Q3 2024 | $111.2M | $2.8M | $0.15 |
| Q2 2024 | $110.6M | $1.3M | $0.07 |
| Q1 2024 | $108.6M | $860.0K | $0.04 |
| Q3 2023 | $104.5M | $90.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Natures Sunshine Products Inc. Dividends, Buybacks & Capital Allocation
NATR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Natures Sunshine Products Inc. (CIK: 0000275053)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 22, 2026 | 4 | xslF345X06/wk-form4_1779465592.xml | View → |
| May 20, 2026 | 4 | xslF345X06/wk-form4_1779293865.xml | View → |
| May 19, 2026 | 4 | xslF345X06/wk-form4_1779228271.xml | View → |
| May 19, 2026 | 4 | xslF345X06/wk-form4_1779228181.xml | View → |
| May 19, 2026 | 4 | xslF345X06/wk-form4_1779228175.xml | View → |
❓ Frequently Asked Questions about NATR
What is the AI rating for NATR?
Natures Sunshine Products Inc. (NATR) has a Combined AI Grade of B from Claude (B) and ChatGPT (B) with 72% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NATR's key strengths?
Claude: Exceptional gross margin of 73.2% demonstrates strong pricing power in pharmaceutical segment. Fortress balance sheet with $87.6M cash, $2.1M debt, and 0.01x debt-to-equity ratio. ChatGPT: Net cash balance sheet with negligible debt and strong coverage. High gross margin and good FCF conversion (6% FCF margin).
What are the risks of investing in NATR?
Claude: Negative operating cash flow (-$1.8M) and free cash flow (-$4.3M) despite positive earnings signals quality-of-earnings or working capital deterioration. Abysmal capital returns with ROE of 3.1% and ROA of 2.0% despite healthy margins indicates operational inefficiency. ChatGPT: Low operating margin (5.2%) limits earnings scalability. Regulatory/channel risks in supplements and FX exposure.
What is NATR's revenue and growth?
Natures Sunshine Products Inc. reported revenue of $122.9M.
Does NATR pay dividends?
Natures Sunshine Products Inc. does not currently pay dividends.
Where can I find NATR SEC filings?
Official SEC filings for Natures Sunshine Products Inc. (CIK: 0000275053) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NATR's EPS?
Natures Sunshine Products Inc. has a diluted EPS of $0.29.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is NATR's fundamental grade?
Based on our AI fundamental analysis in May 2026, Natures Sunshine Products Inc. has a B grade with 72% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is NATR stock overvalued or undervalued?
Valuation metrics for NATR: ROE of 3.1% (sector avg: 15%), net margin of 4.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is NATR's AI grade for 2026?
Our dual AI analysis gives Natures Sunshine Products Inc. a combined B grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NATR's free cash flow?
Natures Sunshine Products Inc.'s operating cash flow is $-1.8M, with capital expenditures of $2.5M. FCF margin is -3.5%.
How does NATR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 4.2% (avg: 12%), ROE 3.1% (avg: 15%), current ratio 2.50 (avg: 2).